THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SY
发明人:
Zheng Chen,Seung-Hee Yoo,Joseph S. Takahashi
申请号：
US15911781
公开号：
US20180296523A1
申请日:
2018.03.05
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed are methods comprising administering to a mammal suffering from, or at risk of suffering from, a clock-controlled disorder, such as metabolic syndrome or a constituent condition thereof, a composition comprising at least one polymethoxylated flavone. Disclosed are methods comprising administering a composition comprising at least one polymethoxylated flavone to a mammal suffering from or at risk of suffering from a sleep disorder； suffering from aging； and/or suffering from or at risk of suffering from a mood disorder. The polymethoxylated flavone may be nobiletin and/or tangeretin. The composition may also comprise other compounds, such as nicotinamide riboside and/or pterostilbene, and/or other compounds expected to improve one or more symptoms of metabolic syndrome, a sleep disorder, a mood disorder, aging, a cardiovascular disease, an immune disorder, a neurodegenerative disease, and/or a cancer.
